The results of a study which focused on the impact of introducing a smartphone-based daily feedback and communication platform between gestational diabetes mellitus patients and their physicians, have been published in the American Journal of Obstetrics and Gynecology.
The randomised controlled trial involved the analysis of 120 newly-diagnosed gestational diabetes mellitus patients.
- Group 1: Routine biweekly prenatal clinic care (the control group)
- Group 2: Additional daily detailed feedback on compliance and glycemic control from the clinic team via an application installed on the patient’s smartphone (the smartphone group).
The report concluded that the introduction of a smartphone-based daily feedback and communication platform between gestational diabetes mellitus patients and the multidisciplinary diabetes-in-pregnancy clinic team, helped improve patient compliance and glycemic control, and lowered the rate of insulin treatment.
Links to the abstract and further details can be found here*.
* Miremberg H, Ben-Ari T, Betzer T et al. The impact of a daily smartphone-based feedback system among women with gestational diabetes on compliance, glycemic control, satisfaction, and pregnancy outcome: a randomized controlled trial. Am J Obstet Gynecol 2018; 6 February 2018.
Keep up to date with the latest research and news from MIDIRS by subscribing to our quarterly academic journal. Subscribe to MIDIRS Midwifery Digest